SCHEMBL25379016

SCHEMBL25379016

COC(=O)C1CCC(n2ccc(O)nc2=O)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.36
▸ PDE7A Q13946 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ PDE3B Q13370 1/20 0.35
▸ PDE3A Q14432 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ PKM P14618 1/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ WNT1 P04628 1/20 0.35
▸ GSK3B P49841 1/20 0.35
▸ DYRK1A Q13627 1/20 0.35
▸ OPRM1 P35372 1/20 0.35
▸ OPRD1 P41143 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30442517 1.00 SMN1; SMN2 (0.38) SMN1; SMN2MEN1KMT2AALDH1A1PDE7A
SCHEMBL25381623 0.85 LMNA (0.40) SMN1; SMN2MEN1KMT2AALDH1A1PDE7A
SCHEMBL30442514 0.85 LMNA (0.40) SMN1; SMN2MEN1KMT2AALDH1A1PDE7A
SCHEMBL32677974 0.73 ALDH1A1 (0.51) SMN1; SMN2MEN1KMT2AALDH1A1KDM4E
SCHEMBL32677973 0.73 ALDH1A1 (0.51) SMN1; SMN2MEN1KMT2AALDH1A1KDM4E
SCHEMBL25380468 0.72 HTT (0.42) MEN1KMT2AALDH1A1KDM4ELMNA
SCHEMBL25380464 0.72 HTT (0.42) MEN1KMT2AALDH1A1KDM4ELMNA
SCHEMBL29168362 0.70 MAP4K1 (0.38) SMN1; SMN2MEN1KMT2AALDH1A1KDM4E
SCHEMBL31611389 0.70 ALDH1A1 (0.43) SMN1; SMN2ALDH1A1HTT
SCHEMBL29844145 0.70 SMN1; SMN2 (0.38) SMN1; SMN2MEN1KMT2AALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250084041-A1 ANTIMICROBIAL COMPOUNDS AND METHODS THE UNIVERSITY OF UTAH RESEARCH FOUNDATION 2025-03-13 — — US disclosed
WO-2023129963-A1 ANTIMICROBIAL COMPOUNDS AND METHODS CURZA GLOBAL, LLC (US) 2023-07-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250084041-A1 ANTIMICROBIAL COMPOUNDS AND METHODS MPO, NISCH, RPN2 SMN1; SMN2 4817/4885MEN1 4216/4885KMT2A 4067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback